Smoking Is Associated With Epicardial Coronary Endothelial Dysfunction and Elevated White Blood Cell Count in Patients With Chest Pain and Early Coronary Artery Disease
暂无分享,去创建一个
[1] L. Lerman,et al. Dietary reversal of experimental hypercholesterolemia improves endothelial dysfunction of epicardial arteries but not of small coronary vessels in pigs. , 2006, Atherosclerosis.
[2] C. Heeschen,et al. Differential effects of short-term lipid lowering with ezetimibe and statins on endothelial function in patients with CAD: clinical evidence for 'pleiotropic' functions of statin therapy. , 2006, European heart journal.
[3] Paul M Ridker,et al. C-reactive protein and other emerging blood biomarkers to optimize risk stratification of vulnerable patients. , 2006, Journal of the American College of Cardiology.
[4] H. Klemm,et al. Heparins Increase Endothelial Nitric Oxide Bioavailability by Liberating Vessel-Immobilized Myeloperoxidase , 2006, Circulation.
[5] L. Lerman,et al. Lipoprotein-Associated Phospholipase A2 Is an Independent Marker for Coronary Endothelial Dysfunction in Humans , 2006, Arteriosclerosis, thrombosis, and vascular biology.
[6] S. Daniels,et al. Tobacco Smoke Exposure Is Associated With the Metabolic Syndrome in Adolescents , 2005, Circulation.
[7] G. Abel,et al. Effects of biochemically confirmed smoking cessation on white blood cell count. , 2005, Mayo Clinic proceedings.
[8] A. Larsson,et al. Active smoking and a history of smoking are associated with enhanced prostaglandin F(2alpha), interleukin-6 and F2-isoprostane formation in elderly men. , 2005, Atherosclerosis.
[9] H. White,et al. White Blood Cell Count Predicts Reduction in Coronary Heart Disease Mortality With Pravastatin , 2005, Circulation.
[10] J. Manson,et al. Leukocyte count as a predictor of cardiovascular events and mortality in postmenopausal women: the Women's Health Initiative Observational Study. , 2005, Archives of internal medicine.
[11] A. Zeiher,et al. Endothelial Function: Cardiac Events , 2005, Circulation.
[12] S. Fichtlscherer,et al. Prognostic Value of Systemic Endothelial Dysfunction in Patients With Acute Coronary Syndromes: Further Evidence for the Existence of the “Vulnerable” Patient , 2004, Circulation.
[13] Marlene Goormastic,et al. Serum Myeloperoxidase Levels Independently Predict Endothelial Dysfunction in Humans , 2004, Circulation.
[14] H. Hashimoto,et al. Association between white blood cell count and carotid arteriosclerosis in Japanese smokers. , 2004, Atherosclerosis.
[15] J. Ambrose,et al. The pathophysiology of cigarette smoking and cardiovascular disease: an update. , 2004, Journal of the American College of Cardiology.
[16] U. Goldbourt,et al. Predictive value of elevated white blood cell count in patients with preexisting coronary heart disease: the Bezafibrate Infarction Prevention Study. , 2004, Archives of internal medicine.
[17] W. Koenig,et al. Independent association of various smoking characteristics with markers of systemic inflammation in men. Results from a representative sample of the general population (MONICA Augsburg Survey 1994/95). , 2003, European heart journal.
[18] Amir Lerman,et al. Coronary Endothelial Dysfunction Is Associated With an Increased Risk of Cerebrovascular Events , 2003, Circulation.
[19] V. Fuster,et al. Role of Risk Factors in the Modulation of Tissue Factor Activity and Blood Thrombogenicity , 2003, Circulation.
[20] Amir Lerman,et al. Endothelial Dysfunction: A Marker of Atherosclerotic Risk , 2003, Arteriosclerosis, thrombosis, and vascular biology.
[21] F. Fennessy,et al. Taurine and Vitamin C Modify Monocyte and Endothelial Dysfunction in Young Smokers , 2003, Circulation.
[22] M. Sabatine,et al. Relationship between baseline white blood cell count and degree of coronary artery disease and mortality in patients with acute coronary syndromes , 2002 .
[23] M. Watkins,et al. Risk Stratification for Postoperative Cardiovascular Events via Noninvasive Assessment of Endothelial Function: A Prospective Study , 2002, Circulation.
[24] J. Ambrose,et al. Dysfunctional Endothelial Nitric Oxide Biosynthesis in Healthy Smokers With Impaired Endothelium-Dependent Vasodilatation , 2001, Circulation.
[25] Incremental doses of intracoronary adenosine for the assessment of coronary velocity reserve for clinical decision making , 2001, Catheterization and cardiovascular interventions : official journal of the Society for Cardiac Angiography & Interventions.
[26] S. Hazen,et al. Nitric Oxide Is a Physiological Substrate for Mammalian Peroxidases* , 2000, The Journal of Biological Chemistry.
[27] D. Harrison,et al. Endothelial dysfunction in cardiovascular diseases: the role of oxidant stress. , 2000, Circulation research.
[28] S. Hazen,et al. Nitric oxide is a substrate for mammalian peroxidases , 2000 .
[29] C. Packard,et al. Lipoprotein-associated phospholipase A2, platelet-activating factor acetylhydrolase: a potential new risk factor for coronary artery disease , 2000 .
[30] O. Raitakari,et al. Oral vitamin C and endothelial function in smokers: short-term improvement, but no sustained beneficial effect. , 2000, Journal of the American College of Cardiology.
[31] S. Higano,et al. Long-term follow-up of patients with mild coronary artery disease and endothelial dysfunction. , 2000, Circulation.
[32] S. Higano,et al. Measuring maximal percent area stenosis poststent placement with intracoronary Doppler and the continuity equation and correlation with intracoronary ultrasound and angiography. , 1999, The American journal of cardiology.
[33] D. Webb,et al. Endothelial dysfunction, impaired endogenous fibrinolysis, and cigarette smoking: a mechanism for arterial thrombosis and myocardial infarction. , 1999, Circulation.
[34] R. Virmani,et al. Effect of risk factors on the mechanism of acute thrombosis and sudden coronary death in women. , 1998, Circulation.
[35] G. Opdenakker,et al. The molecular basis of leukocytosis. , 1998, Immunology today.
[36] E. Boerwinkle,et al. Circulating adhesion molecules VCAM-1, ICAM-1, and E-selectin in carotid atherosclerosis and incident coronary heart disease cases: the Atherosclerosis Risk In Communities (ARIC) study. , 1997, Circulation.
[37] R. Gibbons,et al. Coronary endothelial dysfunction in humans is associated with myocardial perfusion defects. , 1997, Circulation.
[38] R. Virmani,et al. Coronary risk factors and plaque morphology in men with coronary disease who died suddenly. , 1997, The New England journal of medicine.
[39] G. Levine,et al. Ascorbic acid reverses endothelial vasomotor dysfunction in patients with coronary artery disease. , 1996, Circulation.
[40] M. Bell,et al. Endothelin in coronary endothelial dysfunction and early atherosclerosis in humans. , 1995, Circulation.
[41] A. Zeiher,et al. Long-term cigarette smoking impairs endothelium-dependent coronary arterial vasodilator function. , 1995, Circulation.
[42] M. Phelps,et al. Effect of acute and long-term smoking on myocardial blood flow and flow reserve. , 1995, Circulation.
[43] J. Morrow,et al. Increase in circulating products of lipid peroxidation (F2-isoprostanes) in smokers. Smoking as a cause of oxidative damage. , 1995, The New England journal of medicine.
[44] D. Celermajer,et al. Cigarette Smoking Is Associated With Dose‐Related and Potentially Reversible Impairment of Endothelium‐Dependent Dilation in Healthy Young Adults , 1993, Circulation.
[45] K. Anderson,et al. White blood cell count and cardiovascular disease. Insights from the Framingham Study. , 1992, JAMA.
[46] William A. Pryor,et al. The Tar Radical ( s ) in Cigarette Smoke : ESR Studies , 2006 .